Literature DB >> 22135646

Increased oxidative stress in patients with familial Mediterranean fever during attack period.

L Ediz1, H Ozkol, I Tekeoglu, Y Tuluce, E Gulcu, I Koyuncu.   

Abstract

OBJECTIVES: We aimed to investigate the status of oxidant and antioxidants during attack period (AP) and attack free periods (AFP) in Familial Mediterranean fever (FMF) patients.
METHODS: Measured the levels of malondialdehyde (MDA), protein carbonyl (PC), glutathione (GSH) and antioxidant vitamins (A,C and E) as well as the activities of catalase (CAT) and glutathione peroxidase (GSH-Px) in serum and whole blood of FMF patients in FMF-AP and FMF-AFP.
RESULTS: Levels of MDA and PC were found significantly higher (p <0.05) both in serum and whole blood of FMF-AP group compared with other groups. The CAT and GSH-Px activities in FMF-AP group were found markedly lower (p <0.05) comparing to HC group. However, there were no statistically significant differences between the groups in terms of antioxidant vitamin levels.
CONCLUSIONS: Our study demonstrated increased oxidative stress in patients with FMF during AP. Investigations are needed to establish the effect of antioxidant supplementation on FMF attack frequency and severity. We also suggest that these increased MDA and PC levels and decreased antioxidants may be used as supportive markers to differentiate AP from AFP. These conclusions need to be validated in further multicenter studies with high number of FMF patients.

Entities:  

Keywords:  Antioxidant enzymes; Antioxidant vitamins; Familial Mediterranean fever; Lipid peroxidation; Protein oxidation

Mesh:

Year:  2011        PMID: 22135646      PMCID: PMC3220131          DOI: 10.4314/ahs.v11i3.70063

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  47 in total

Review 1.  Biomarkers of oxidative stress: an analytical approach.

Authors:  P Thérond; D Bonnefont-Rousselot; A Davit-Spraul; M Conti; A Legrand
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2000-09       Impact factor: 4.294

Review 2.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

Review 3.  Familial mediterranean Fever in the world.

Authors:  Eldad Ben-Chetrit; Isabelle Touitou
Journal:  Arthritis Rheum       Date:  2009-10-15

Review 4.  Oxidative stress in acute pancreatitis.

Authors:  H U Schulz; C Niederau; H Klonowski-Stumpe; W Halangk; R Luthen; H Lippert
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

5.  The glutathione defense system in the pathogenesis of rheumatoid arthritis.

Authors:  M Q Hassan; R A Hadi; Z S Al-Rawi; V A Padron; S J Stohs
Journal:  J Appl Toxicol       Date:  2001 Jan-Feb       Impact factor: 3.446

6.  Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis.

Authors:  S Taysi; F Polat; M Gul; R A Sari; E Bakan
Journal:  Rheumatol Int       Date:  2002-03       Impact factor: 2.631

7.  Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis.

Authors:  M Y Cimen; O B Cimen; M Kaçmaz; H S Oztürk; R Yorgancioğlu; I Durak
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

8.  Colchicine modulates oxidative stress in serum and leucocytes from remission patients with Family Mediterranean Fever through regulation of Ca²+ release and the antioxidant system.

Authors:  Mehmet Sahin; A Cihangir Uğuz; Halil Demirkan; Mustafa Nazıroğlu
Journal:  J Membr Biol       Date:  2011-01-20       Impact factor: 1.843

9.  Trace elements and antioxidant enzymes in Behçet's disease.

Authors:  K Saglam; A F Serce; M I Yilmaz; F Bulucu; A Aydin; C Akay; A Sayal
Journal:  Rheumatol Int       Date:  2002-05-18       Impact factor: 2.631

Review 10.  Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.

Authors:  Jae J Chae; Ivona Aksentijevich; Daniel L Kastner
Journal:  Br J Haematol       Date:  2009-05-14       Impact factor: 6.998

View more
  5 in total

1.  Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study.

Authors:  Micol Romano; Facundo Garcia-Bournissen; David Piskin; Ulkumen Rodoplu; Lizzy Piskin; Abdelbaset A Elzagallaai; Tunc Tuncer; Siren Sezer; Didar Ucuncuoglu; Tevfik Honca; Dimitri Poddighe; Izzet Yavuz; Peter Stenvinkel; Mahmut Ilker Yilmaz; Erkan Demirkaya
Journal:  Life (Basel)       Date:  2022-06-15

2.  Increased levels of macrophage migration inhibitory factor in patients with familial mediterranean Fever.

Authors:  Yusuf Savran; Ismail Sari; Didem Leyla Kozaci; Necati Gunay; Fatos Onen; Servet Akar
Journal:  Int J Med Sci       Date:  2013-04-30       Impact factor: 3.738

3.  Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?

Authors:  Ahmet Omma; Sevinc Can Sandikci; Orhan Kücüksahin; Murat Alisik; Ozcan Erel
Journal:  J Korean Med Sci       Date:  2017-10       Impact factor: 2.153

4.  Glutathione-S-Transferase Variants are not Associated With Increased Carotid Intima-Media Thickness in Turkish Familial Mediterranean Fever Patients.

Authors:  Özlem Gürbüz; Binnur Bağci; Can Hüzmeli; Gökhan Bağci; Ferhan Candan
Journal:  Arch Rheumatol       Date:  2015-11-03       Impact factor: 1.472

5.  Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation.

Authors:  Jelena Milenković; Jelena Vojinović; Maruša Debeljak; Nataša Toplak; Dragana Lazarević; Tadej Avčin; Tatjana Jevtović-Stoimenov; Dušica Pavlović; Vladmila Bojanić; Maja Milojković; Gordana Kocić; Andrej Veljković
Journal:  Pediatr Rheumatol Online J       Date:  2016-07-01       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.